Pfas Litigation News Today

Rising health concerns over PFAS in food & beverage prompt new state bans, increased litigation, and urgent need for industry compliance.

Medical monitoring costs is not a new for PFAS litigation, few states allow for medical monitoring costs to be pled as cause of action unto itself.ALI's approach of awarding medical monitoring costs absent any injury is a highly controversial recommendation upending tort law

Supplier, Kidde-Fenwal is routinely named in PFAS litigation which alleges that a PFAS-containing AFFF product contributed to environmental pollution or personal injury. Kidde-Fenwal filed for bankruptcy protection in the Delaware court system, citing PFAS litigation costs

PFAS litigation world, medical monitoring claims become claim finds its way into PFAS cases with ever-increasing risks and cost to companies. On November 15, 2022, viability of medical monitoring claims with respect to PFAS in New Hampshire Supreme Court for oral argument.

A lawsuit brought against 3M and Wolverine Worldwide, a downstream PFAS user that dumped PFAS waste that contaminated surrounding lands led to a $54 million settlement. A reminder that companies with use of PFAS must conduct full risk assessment and risk management protocols.

PFAS litigation in the United States has centered on lawsuits filed against PFAS manufacturers for environmental cleanup and remediation. Recently in Europe, PFAS manufacturer 3M agreed to settle PFAS environmental pollution claims brought by Belgium for $581 million.

PFAS and cosmetics is a topic that saw increased scrutiny from the scientific community, legislature, and the media in 2021. As we predicted in early 2021, the increased attention on the industry presented significant risks to the cosmetics industry.

Tuesday, January 12, 2021 For the past three years, we have put forth the prediction that the PFAS litigation would evolve by expanding beyond lawsuits against PFAS manufacturers for personal injuries to lawsuits against manufacturing companies that utilize PFAS as a component of their products. This “next wave” of PFAS product liability cases would significantly impact business interests at an incredible financial magnitude and puts at risk corporate finances at levels that could...